Sei Investments CO Acadia Pharmaceuticals Inc Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Sei Investments CO holds 32,031 shares of ACAD stock, worth $546,769. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,031

Previous 32,734 2.15%

Holding current value

$546,769

Previous $531,000 7.34%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.14 - $19.14 $10,643 - $13,455	-703 Reduced 2.15%	32,031 $492,000
Q2 2024 Aug 13, 2024	SELL	$14.62 - $18.42 $29,503 - $37,171	-2,018 Reduced 5.81%	32,734 $531,000
Q1 2024 May 07, 2024	BUY	$17.79 - $30.86 $36,184 - $62,769	2,034 Added 6.22%	34,752 $642,000
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $404,648 - $618,657	-19,473 Reduced 37.31%	32,718 $1.02 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $525,668 - $844,247	25,224 Added 93.54%	52,191 $1.09 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $45,229 - $65,176	2,541 Added 10.4%	26,967 $645,000
Q1 2023 May 12, 2023	BUY	$16.32 - $20.92 $83,117 - $106,545	5,093 Added 26.34%	24,426 $459,000
Q4 2022 Feb 10, 2023	BUY	$14.2 - $18.63 $94,515 - $124,001	6,656 Added 52.5%	19,333 $307,000
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $6,730 - $8,714	-477 Reduced 3.63%	12,677 $207,000
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $1.5 Million - $3.14 Million	-115,453 Reduced 89.77%	13,154 $179,000
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $508,255 - $667,480	-24,272 Reduced 15.88%	128,607 $3.12 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $23,875 - $38,521	-1,422 Reduced 0.92%	152,879 $3.57 Million
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $42,795 - $67,176	-2,712 Reduced 1.73%	154,301 $2.56 Million
Q2 2021 Aug 06, 2021	SELL	$19.4 - $27.42 $150,912 - $213,300	-7,779 Reduced 4.72%	157,013 $3.83 Million
Q1 2021 May 12, 2021	BUY	$25.02 - $54.99 $1.43 Million - $3.14 Million	57,095 Added 53.01%	164,792 $4.68 Million
Q4 2020 Feb 08, 2021	BUY	$41.04 - $56.79 $1.03 Million - $1.43 Million	25,096 Added 30.38%	107,697 $5.73 Million
Q3 2020 Nov 06, 2020	SELL	$36.42 - $57.0 $661,168 - $1.03 Million	-18,154 Reduced 18.02%	82,601 $3.4 Million
Q2 2020 Aug 17, 2020	BUY	$39.26 - $52.73 $59,125 - $79,411	1,506 Added 1.52%	100,755 $4.88 Million
Q2 2020 Aug 11, 2020	SELL	$39.26 - $52.73 $400,962 - $538,531	-10,213 Reduced 9.33%	99,249 $4.34 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $244,654 - $362,305	7,730 Added 7.6%	109,462 $4.63 Million
Q4 2019 Feb 06, 2020	SELL	$36.21 - $51.4 $92,987 - $131,995	-2,568 Reduced 2.46%	101,732 $4.35 Million
Q3 2019 Nov 12, 2019	BUY	$22.22 - $44.01 $400,848 - $793,940	18,040 Added 20.91%	104,300 $3.75 Million
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $249,780 - $301,193	10,711 Added 14.18%	86,260 $2.31 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $1.15 Million - $1.95 Million	71,168 Added 1624.47%	75,549 $2.03 Million
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $149,644 - $239,514	-10,450 Reduced 70.46%	4,381 $91,000
Q3 2018 Nov 08, 2018	SELL	$13.03 - $21.81 $459,646 - $769,369	-35,276 Reduced 70.4%	14,831 $316,000
Q2 2018 Aug 03, 2018	BUY	$15.07 - $22.34 $740,991 - $1.1 Million	49,170 Added 5247.6%	50,107 $766,000
Q1 2018 May 11, 2018	SELL	$22.47 - $32.33 $476,903 - $686,171	-21,224 Reduced 95.77%	937 $21,000
Q4 2017 Feb 08, 2018	BUY	$26.84 - $39.14 $69,515 - $101,372	2,590 Added 13.23%	22,161 $667,000
Q3 2017 Nov 06, 2017	BUY	$29.49 - $38.37 $577,148 - $750,939	19,571	19,571 $737,000

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Acadia Pharmaceuticals Inc Transaction History